Related references
Note: Only part of the references are listed.Ultra fast symmetry and SIMD-based projection-backprojection (SSP) algorithm for 3-D PET image reconstruction
I. K. Hong et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2007)
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I
H. Umesha Shetty et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Assessment of 11C-PE2I binding to the neuronal dopamine transporter in humans with the high-spatial-resolution PET scanner HRRT
Claire Leroy et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner
Hugo W. A. M. de Jong et al.
PHYSICS IN MEDICINE AND BIOLOGY (2007)
Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET
Andrew J. Montgomery et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-C-11]WAY-100635 - considerations on the validity of cerebellum as a reference region
Jussi Hirvonen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain:: a PET study
Aurelija Jucaite et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO
M Willeit et al.
BIOLOGICAL PSYCHIATRY (2006)
Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia
J Hirvonen et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2006)
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity
A Jucaite et al.
BIOLOGICAL PSYCHIATRY (2005)
[11C]PE2I:: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain
C Halldin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Quantification of [123I]PE2I binding to dopamine transporters with SPET
LH Pinborg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells
G Page et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulation study based on experimental data
H Olsson et al.
NEUROIMAGE (2001)
Imaging human mesolimbic dopamine transmission with positron emission tomography:: I.: Accuracy and precision of D2 receptor parameter measurements in ventral striatum
O Mawlawi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Graphical analysis of PET data applied to reversible and irreversible tracers
J Logan
NUCLEAR MEDICINE AND BIOLOGY (2000)
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans:: Comparison of arterial and reference tissue input functions
RV Parsey et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)